Preimplantation genetic diagnosis (PGD) is performed among couples with a higher risk of transmitting a genetic condition to their offspring. The technique is employed in in-vitro fertilization centers globally to select the euploid embryos to transfer and improve the clinical outcome of the clinical pregnancy, embryo implantation, and live birth rates. As per a research study published by MDPI, embryo aneuploidy is one of the significant reasons for IVF failure enhancing the importance of the preimplantation genetic testing for aneuploidies as a mode of selecting healthy embryos with normal chromosomes. The ability to identify the preimplantation embryos with the genetic defects prior to the initiation of the pregnancy also offers an attractive alternative to chorionic villous sampling or amniocentesis.

1 Product Definition 

2 Research Methodology 

3 Market Overview 

4 Market Dynamics 

5 Industry Analysis 

6 Competitive Landscape 

7 Global Preimplantation Genetic Testing Market, by Product, 2020-2031